Weekly Trademark Review March 8, 2016
This article was originally published in The Tan Sheet
OTC drug, personal care product and nutritional supplement trademark filings compiled by “The Tan Sheet” from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps; and Class 5 – Pharmaceuticals.
You may also be interested in...
Emerald Health Therapeutics has Whole Foods Markets carrying its products while Diamond CBD pitches its line to CVS Health. Axim Biotechnologies plans to explore production of CBD-based toothpaste as first product under recently patented formulation.
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.
Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.